達邦蛋白（6578） 2026 年 8 月營收為 3,400.50 萬元，較上月減少 9.84%，較去年同月增加 97.36%。2026 年 1–8 月累計營收為 2.61 億元，較去年同期增加 29.50%。
| 所屬月份 | 營收（元） | 月增率 | 年增率 |
|---|---|---|---|
| 2026-08 | 34,005,000 | -9.84% | 97.36% |
| 2026-07 | 37,717,000 | 7.05% | 50.45% |
| 2026-06 | 35,234,000 | -1.79% | 35.80% |
| 2026-05 | 35,877,000 | -1.36% | 27.22% |
| 2026-04 | 36,372,000 | 7.05% | -0.95% |
| 2026-03 | 33,976,000 | 52.18% | 24.00% |
| 2026-02 | 22,326,000 | -13.43% | 39.97% |
| 2026-01 | 25,789,000 | -10.70% | 2.14% |
| 2025-12 | 28,880,000 | 18.08% | 74.69% |
| 2025-11 | 24,457,000 | -11.27% | -30.24% |
| 2025-10 | 27,563,000 | 3.35% | -8.36% |
| 2025-09 | 26,669,000 | 54.78% | 101.76% |
| 2025-08 | 17,230,000 | -31.27% | -20.92% |
| 2025-07 | 25,070,000 | -3.38% | 14.19% |
| 2025-06 | 25,946,000 | -8.00% | 37.41% |
| 2025-05 | 28,201,000 | -23.20% | -28.13% |
| 2025-04 | 36,722,000 | 34.03% | -7.94% |
| 2025-03 | 27,399,000 | 71.78% | -20.37% |
| 2025-02 | 15,950,000 | -36.83% | -40.71% |
| 2025-01 | 25,248,000 | 52.72% | -36.67% |
| 2024-12 | 16,532,000 | -52.85% | -52.78% |
| 2024-11 | 35,061,000 | 16.57% | 2.39% |
| 2024-10 | 30,078,000 | 127.55% | -4.05% |
| 2024-09 | 13,218,000 | -39.33% | -52.24% |
月份為營收所屬月；缺值顯示 —，不補成零。
營收月份為所屬月，非公告日；年增率為與去年同月比較，缺值保留為斷點。